11-22250324-A-T

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_213599.3(ANO5):​c.966A>T​(p.Leu322Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.54 in 1,612,376 control chromosomes in the GnomAD database, including 247,717 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L322L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.44 ( 17544 hom., cov: 32)
Exomes 𝑓: 0.55 ( 230173 hom. )

Consequence

ANO5
NM_213599.3 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:18O:1

Conservation

PhyloP100: 0.00100
Variant links:
Genes affected
ANO5 (HGNC:27337): (anoctamin 5) This gene encodes a member of the anoctamin family of transmembrane proteins. The encoded protein is likely a calcium activated chloride channel. Mutations in this gene have been associated with gnathodiaphyseal dysplasia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a topological_domain Extracellular (size 59) in uniprot entity ANO5_HUMAN there are 7 pathogenic changes around while only 0 benign (100%) in NM_213599.3
BP4
Computational evidence support a benign effect (MetaRNN=2.8172135E-4).
BP6
Variant 11-22250324-A-T is Benign according to our data. Variant chr11-22250324-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 96687.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-22250324-A-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.588 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANO5NM_213599.3 linkc.966A>T p.Leu322Phe missense_variant Exon 10 of 22 ENST00000324559.9 NP_998764.1 Q75V66

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANO5ENST00000324559.9 linkc.966A>T p.Leu322Phe missense_variant Exon 10 of 22 1 NM_213599.3 ENSP00000315371.9 Q75V66

Frequencies

GnomAD3 genomes
AF:
0.441
AC:
66910
AN:
151890
Hom.:
17535
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.164
Gnomad AMI
AF:
0.559
Gnomad AMR
AF:
0.415
Gnomad ASJ
AF:
0.609
Gnomad EAS
AF:
0.199
Gnomad SAS
AF:
0.499
Gnomad FIN
AF:
0.594
Gnomad MID
AF:
0.566
Gnomad NFE
AF:
0.593
Gnomad OTH
AF:
0.486
GnomAD3 exomes
AF:
0.478
AC:
119591
AN:
250046
Hom.:
31869
AF XY:
0.496
AC XY:
66987
AN XY:
135148
show subpopulations
Gnomad AFR exome
AF:
0.157
Gnomad AMR exome
AF:
0.298
Gnomad ASJ exome
AF:
0.602
Gnomad EAS exome
AF:
0.179
Gnomad SAS exome
AF:
0.503
Gnomad FIN exome
AF:
0.590
Gnomad NFE exome
AF:
0.586
Gnomad OTH exome
AF:
0.525
GnomAD4 exome
AF:
0.550
AC:
803860
AN:
1460368
Hom.:
230173
Cov.:
43
AF XY:
0.552
AC XY:
400941
AN XY:
726446
show subpopulations
Gnomad4 AFR exome
AF:
0.152
Gnomad4 AMR exome
AF:
0.312
Gnomad4 ASJ exome
AF:
0.611
Gnomad4 EAS exome
AF:
0.153
Gnomad4 SAS exome
AF:
0.507
Gnomad4 FIN exome
AF:
0.581
Gnomad4 NFE exome
AF:
0.588
Gnomad4 OTH exome
AF:
0.522
GnomAD4 genome
AF:
0.440
AC:
66928
AN:
152008
Hom.:
17544
Cov.:
32
AF XY:
0.440
AC XY:
32712
AN XY:
74276
show subpopulations
Gnomad4 AFR
AF:
0.164
Gnomad4 AMR
AF:
0.415
Gnomad4 ASJ
AF:
0.609
Gnomad4 EAS
AF:
0.199
Gnomad4 SAS
AF:
0.501
Gnomad4 FIN
AF:
0.594
Gnomad4 NFE
AF:
0.593
Gnomad4 OTH
AF:
0.488
Alfa
AF:
0.549
Hom.:
17185
Bravo
AF:
0.407
TwinsUK
AF:
0.576
AC:
2137
ALSPAC
AF:
0.585
AC:
2254
ESP6500AA
AF:
0.180
AC:
794
ESP6500EA
AF:
0.586
AC:
5041
ExAC
AF:
0.480
AC:
58309
Asia WGS
AF:
0.325
AC:
1136
AN:
3476
EpiCase
AF:
0.581
EpiControl
AF:
0.584

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:18Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:10
Jan 07, 2016
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 12, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 13, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

p.Leu322Phe in exon 10 of ANO5: This variant is not expected to have clinical si gnificance because it has been identified in 41.4% (3559/8600) of European Ameri can chromosomes from a broad population by the NHLBI Exome Sequencing Project (h ttp://evs.gs.washington.edu/EVS; dbSNP rs7481951). -

Jul 15, 2015
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 07, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:1Other:1
-
ANO5 @LOVD
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Miyoshi muscular dystrophy 3 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Limb-girdle muscular dystrophy, recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

ANO5-Related Muscle Diseases Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Gnathodiaphyseal dysplasia Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Gnathodiaphyseal dysplasia;C1969785:Autosomal recessive limb-girdle muscular dystrophy type 2L Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2L Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Miyoshi myopathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.10
T
Eigen
Benign
-0.54
Eigen_PC
Benign
-0.45
FATHMM_MKL
Benign
0.084
N
LIST_S2
Benign
0.85
T
MetaRNN
Benign
0.00028
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
1.3
L
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-2.3
N
REVEL
Benign
0.054
Sift
Benign
0.14
T
Sift4G
Uncertain
0.059
T
Polyphen
0.011
B
Vest4
0.046
MutPred
0.17
Loss of catalytic residue at L322 (P = 0.1168);
MPC
0.10
ClinPred
0.0038
T
GERP RS
3.0
Varity_R
0.10
gMVP
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs7481951; hg19: chr11-22271870; COSMIC: COSV61084696; API